Elanco Animal Health (ELAN) Share-based Compensation Growth (1y) (2018 - 2026)
Elanco Animal Health (ELAN) Share-based Compensation Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.44 Bn | 397.90 Mn | 24.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.00% |
| Mar 31, 2026 | 61.54% |
| Dec 31, 2025 | 6.67% |
| Sep 30, 2025 | 13.33% |
| Jun 30, 2025 | 57.14% |
| Mar 31, 2025 | 18.18% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 50.00% |
| Jun 30, 2024 | 55.56% |
| Mar 31, 2024 | -8.33% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -23.08% |
| Jun 30, 2023 | -47.06% |
| Mar 31, 2023 | -14.29% |
| Dec 31, 2022 | -16.67% |
| Sep 30, 2022 | -23.53% |
| Jun 30, 2022 | 6.25% |
| Mar 31, 2022 | -6.67% |
| Dec 31, 2021 | 12.50% |
| Sep 30, 2021 | 41.67% |